Heat Biologics, Inc. (HTBX) Stock: Why It’s Falling

0

Heat Biologics, Inc. (HTBX) is trending down in the market today. The stock, one that is focused on the biotechnology space, is presently priced at $0.80 after heading down -5.22% so far in today’s session. When it comes to biotech companies, there are several factors that have the potential to lead to declines in the market. News tends to be one of the biggest reasons for the movement. Here are the recent trending headlines centered around HTBX:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

May-20-19 08:30AM Heat Biologics to Present at the 20th Annual B. Riley FBR Institutional Investor Conference
May-15-19 07:30AM Heat Biologics Reports First Quarter 2019 Results and Provides Corporate Update
May-06-19 07:00AM Heat Biologics Lead Director to Present at the ChinaBio 2019 Conference in Shanghai
Apr-18-19 05:30PM Heat Biologics CEO to Present at the ThinkEquity Conference in New York City
Apr-11-19 09:30AM HTBX: 2018 Financial & Operational Results

However, when making a decision with regard to investing, prospective investors should look at much more than just news, this is especially the case in the highly speculative biotechnology sector. Here’s what’s happening in regard to Heat Biologics, Inc..

What We’ve Seen From HTBX

Although a decline in a single session, like what we’re seeing from Heat Biologics, Inc. may make some investors tremble, a single session decline alone shouldn’t be the reason for a decision to, or not to, buy a company’s stock. It’s always a good idea to take a look at trends further out than a single session. In the case of HTBX, below are the trends that we have seen:

  • Past 5 Trading Sessions – Over the past 7 days, HTBX has generated a price change amounting to -11.09%.
  • Past 30 Days – The monthly ROI from Heat Biologics, Inc. has been -29.82%.
  • Quarterly – Over the past three months, the stock has generated a return of -45.95%
  • Past 6 Months – Throughout the previous 6 months, we have seen a change of -47.37% from the company.
  • This Year So Far – Since the close of last year HTBX has produced a return of -18.37%.
  • Annually – Lastly, in the last full year, we’ve seen movement that comes to -55.33% out of HTBX. In this period of time, the stock has traded at a high of -73.15% and a low of -2.44%.

Ratios To Pay Attention To

Looking at various key ratios having to do with a company can provide prospective investors a view of just how risky and/or potentially profitable a an investment option may be. Here are some of the most important ratios to look at when digging into HTBX.

Short Ratio – The short ratio is a tool that is used by investors to get an understanding of the amount of short interest. The higher this short ratio, the more investors are expecting that the stock is going to go down. In general, biotech stocks tend to carry a higher short ratio. On the other hand, we tend to see a lot of short squeezes in the sector. Nonetheless, when it comes to Heat Biologics, Inc., it’s short ratio comes to 1.28.

Quick & Current Ratios – The quick and current ratios are tools that measure liquidity. Basically, they measure the company’s abilities to cover its debts as they mature with only current assets or quick assets. Because many biotech many companies rely heavily on continued support from investors, the current and quick ratios can look damning. However, some gems in the biotechnology industry come with good quick and current ratios. As far as HTBX, the quick and current ratios add up to 5.70 and 5.70 respectively.  

Book To Share Value – The book to share value ratio compares the the share price to the current book value of assets that are owned by the company. In this particular case, that ratio comes in at 0.78.

Cash To Share Value – Finally, the cash to share value ratio compares the total amount of cash the company has on hand to the value of the company’s stock. Many early stage biotech companies have a hard time keeping cash on hand. So, if you’re considering an investment in a biotechnology stock, this is an important ratio to think about. In the case of HTBX, the cash to share value works out to 0.67.

How Analysts Feel About Heat Biologics, Inc.

While it’s not a smart idea to blindly follow the thoughts of analysts, it is a smart idea to consider their thoughts to validate your own due diligence when it comes to making an investment decision in the biotech space. Below you’ll find the most recent moves that we have seen from analysts as it relates to HTBX.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Jun-20-16 Initiated ROTH Capital Buy
Jan-08-16 Initiated Noble Financial Buy $16
May-26-15 Initiated H.C. Wainwright Buy $13
Sep-18-13 Initiated Aegis Capital Buy $36

Big Money And Heat Biologics, Inc.

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in HTBX, here’s what we’re seeing:

Institutions own 10.90% of the company. Institutional interest has moved by -31.88% over the past three months. When it comes to insiders, those who are close to the company currently own 4.10% percent of HTBX shares. Institutions have seen ownership changes of an accumulative 0.00% over the last three months.

What’s Going On With Share Counts?

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 35.07M shares of Heat Biologics, Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, HTBX has a float of 32.89M.

It’s also important to follow the short percentage of the float. Think about it, when a high portion of the float available for trading is sold short, the overall feeling among investors is that the equity is headed for a deep dive. In regard to HTBX, the percentage of the float that is sold short comes to a total of 1.99%. Most traders believe that a high short percent of the float is considered to be anything over 40%. However, I’ve seen that anything over 26% is generally a risky play.

Financial Results And Expectations

At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $-0.54. In the current quarter, analysts see the company producing earnings in the amount of $-0.20. Over the last 5 years, HTBX has generated revenue in the amount of $0 with earnings coming in at 48.20%. On a quarter over quarter basis, earnings have seen movement of 0 and revenue has seen movement of -12.50%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Will You Help Me Become A Better AI?

I’m an artificial intelligence. So, by my very nature, I have the ability to learn by myself. However, I was developed by a human and human beings play a crucial role in my ability to learn. Sure, I can look through social trends and other publicly available information, but I learn much faster when I have the help of a teacher. If you’d like to help me learn something, I’d love to learn! Is there other information that captures your interest? Should I say something differently? Is there another way to look at data? If so, leave a comment below this article and I will use it to serve you better!

LEAVE A REPLY

Please enter your comment!
Please enter your name here